TWi Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	332.56	126.8	151.83	160.4	188.84	64.12
Short-Term Investments	-	16	171.85	-	34.3	148.2
Cash & Short-Term Investments	332.56	142.8	323.69	160.4	223.14	212.32
Cash Growth	44.33%	-55.88%	101.80%	-28.12%	5.10%	-45.05%
Other Receivables	0.93	0.89	0.44	0.57	4.13	0.72
Receivables	0.93	0.89	0.44	0.57	4.13	0.72
Inventory	-	-	-	-	-	2.34
Prepaid Expenses	1.21	-	-	1	1.41	1.27
Other Current Assets	-	34.36	0.8	-	-	-
Total Current Assets	334.7	178.05	324.93	161.97	228.68	216.65
Property, Plant & Equipment	4.89	6.56	9.96	5.75	9.54	13.68
Long-Term Investments	-	-	-	1	1	79
Other Intangible Assets	30.25	33.25	39.25	45.25	51.81	58.55
Other Long-Term Assets	23.74	24.46	22.72	20.34	20.01	19.16
Total Assets	393.58	242.32	396.85	234.31	311.04	387.04
Accrued Expenses	49.19	34.75	32.45	10.67	9	8.78
Short-Term Debt	-	10	-	-	-	-
Current Portion of Leases	2.69	2.66	2.37	2.53	2.5	2.46
Current Unearned Revenue	-	-	-	-	-	30.8
Other Current Liabilities	68.49	13.36	12.64	12.43	15.45	43.84
Total Current Liabilities	120.36	60.77	47.45	25.63	26.95	85.88
Long-Term Leases	1.6	2.95	5.6	-	2.53	5.02
Long-Term Unearned Revenue	2.76	2.76	2.76	2.76	2.76	2.03
Total Liabilities	124.72	66.47	55.81	28.39	32.24	92.93
Common Stock	1,076	876.29	877.94	678.34	674.34	674.34
Additional Paid-In Capital	916.25	-	-	830.76	830.5	830.5
Retained Earnings	-1,724	-1,637	-1,472	-1,302	-1,226	-1,211
Comprehensive Income & Other	-	936.25	935.48	-1.19	-	-
Shareholders' Equity	268.86	175.85	341.04	205.92	278.8	294.11
Total Liabilities & Equity	393.58	242.32	396.85	234.31	311.04	387.04
Total Debt	4.28	15.6	7.97	2.53	5.02	7.49
Net Cash (Debt)	328.28	127.2	315.72	157.87	218.11	204.83
Net Cash Growth	46.87%	-59.71%	99.98%	-27.62%	6.48%	-46.63%
Net Cash Per Share	3.73	1.45	4.31	2.34	3.23	3.04
Filing Date Shares Outstanding	107.63	87.63	87.79	67.83	67.43	67.43
Total Common Shares Outstanding	107.63	87.63	87.79	67.83	67.43	67.43
Working Capital	214.34	117.28	277.48	136.34	201.73	130.78
Book Value Per Share	2.50	2.01	3.88	3.04	4.13	4.36
Tangible Book Value	238.61	142.6	301.79	160.67	226.99	235.57
Tangible Book Value Per Share	2.22	1.63	3.44	2.37	3.37	3.49
Machinery	8.99	10.55	10.25	10.25	10.25	10.02
Leasehold Improvements	-	4.85	4.85	4.85	4.85	4.85

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.